News
Readers pointed to the incumbent’s domain expertise and broad member base outweighing Amazon’s innovative nature.
Both companies focus on engaging patients through health apps, and analyzing their collected data for insights using AI.
Executives explain how the developer initiatives work and why they’re fueling innovation and shaping future direction of their platforms.
CHC Program Chair Dr. Joseph Kvedar says the event will focus on technology coming in the next 18 to 24 months.
Consumer genomics company Helix has partnered with MyVytalics on a new app that gives users insights about how their genes play into their sleep patterns and health.
A new JAMA Cardiology study revealed that while telemonitoring helps lower blood pressure in patients with uncontrolled hypertension, the results are not long lasting.
Plan members who took to the platform reduced their medical expenses and filled fewer prescriptions, while outcomes remained similar or become worse for those who did not engage.
The follow-up to Nima's gluten sensor picked up peanut proteins with 99.2 percent accuracy in a third-party test.
NeuroFlow said that it is targeting major health systems with its product, and anticipates a total subscription of $1.5 million by the end of its fundraising.
Masimo's acoustic respiration sensor, the RAS-45 for Rainbow Acoustic Monitoring, is clearedfor use among infants and neotal patients 10kg and under.